05 Dec 2018
The second Life Sciences Sector Deal will support healthcare innovation and back businesses to create high-paid, high-quality jobs as part of the government’s modern Industrial Strategy.
In Manchester, healthcare company Roche, will invest £20 million investment over three years in a precision cancer research partnership with the Christie NHS Foundation Trust in Manchester. This will use cutting-edge genomic technology and big data to accelerate the next generation of digital clinical trials for rare cancers, making the UK a leading global hub for rare cancer trials, potentially benefiting nearly 5,000 patients annually.
Commenting on the news, Prof Ben Bridgewater, Chief Executive of Health Innovation Manchester, said: “The news further cements Manchester’s position as being at the leading edge of precision healthcare and is fast becoming a global life sciences cluster. This is further enhanced by devolution and our strong expertise in tech, digital and data sciences.”
Read the full release on the Gov.uk website